Biopharmaceutical professional with 30 years of industry experience, including over 20 years of global direct experience leading the Quality function for a number of industry leaders, from preclinical to commercialization of therapeutic drugs. Industry experience includes autologous cellular immunotherapies, monoclonal antibodies, protein therapeutics, vaccines, small molecule therapeutics, gene therapy, regulatory agencies interaction, and regulatory submissions.
Vice President, Head of CMC at Arbor Biotechnologies
Master's degree, Biotechnology